[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,682,712
  • Shares Outstanding, K 2,042,071
  • Annual Sales, $ 48,194 M
  • Annual Income, $ 7,054 M
  • EBIT $ 12,521 M
  • EBITDA $ 16,532 M
  • 60-Month Beta 0.26
  • Price/Sales 2.38
  • Price/Cash Flow 6.92
  • Price/Book 5.71

Options Overview Details

View History
  • Implied Volatility 25.86% (-0.11%)
  • Historical Volatility 29.45%
  • IV Percentile 12%
  • IV Rank 26.21%
  • IV High 40.88% on 11/19/25
  • IV Low 20.52% on 12/31/25
  • Expected Move (DTE 5) 1.29 (2.30%)
  • Put/Call Vol Ratio 0.45
  • Today's Volume 20,254
  • Volume Avg (30-Day) 21,987
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 608,720
  • Open Int (30-Day) 557,831
  • Expected Range 54.87 to 57.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.63
  • Number of Estimates 11
  • High Estimate $1.71
  • Low Estimate $1.55
  • Prior Year $1.46
  • Growth Rate Est. (year over year) +11.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.57 +1.06%
on 05/07/26
60.78 -7.60%
on 04/30/26
-3.04 (-5.14%)
since 04/08/26
3-Month
55.57 +1.06%
on 05/07/26
62.89 -10.70%
on 03/02/26
-5.83 (-9.40%)
since 02/06/26
52-Week
42.52 +32.08%
on 10/29/25
62.89 -10.70%
on 03/02/26
+9.28 (+19.80%)
since 05/08/25

Most Recent Stories

More News
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with...

BMY : 56.16 (-0.16%)
Bristol-Myers Squibb’s Q1 Earnings Call: Our Top 5 Analyst Questions

Bristol-Myers Squibb’s Q1 Earnings Call: Our Top 5 Analyst Questions

BMY : 56.16 (-0.16%)
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026

Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at the Bank of America Securities Healthcare Conference 2026 on Thursday, May 14, 2026. The company...

BMY : 56.16 (-0.16%)
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges

1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges

SUPN : 51.53 (-1.43%)
ELV : 378.07 (+1.38%)
BMY : 56.16 (-0.16%)
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™

Campaign Highlights BMS’ Relentless Drive to Advance Breakthroughs for Patients

BMY : 56.16 (-0.16%)
BMY Q1 Deep Dive: Growth Portfolio, Pipeline Milestones, and Anticipated Late-Stage Readouts

BMY Q1 Deep Dive: Growth Portfolio, Pipeline Milestones, and Anticipated Late-Stage Readouts

BMY : 56.16 (-0.16%)
Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations

Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations

BMY : 56.16 (-0.16%)
Bristol Myers Squibb Reports First Quarter Financial Results for 2026

Bristol Myers Squibb (NYSE: BMY) today reported first quarter 2026 financial results. Visit the company’s Investor Relations website at http://investor.bms.com ...

BMY : 56.16 (-0.16%)
Bristol-Myers Squibb's Pipeline Narrative Meets Its Patent Cliff Reality

Barchart Research What to Expect from BMY Earnings BMY Generated April 29, 2026 Current Price $57.59 EPS Estimate $$1.44 Consensus Rating Moderate Buy Average Move 5.78% Bristol-Myers Squibb's Pipeline...

BMY : 56.16 (-0.16%)
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Although Bristol-Myers Squibb has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

XLV : 143.49 (-0.85%)
$SPX : 7,398.93 (+0.84%)
BMY : 56.16 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 57.30
2nd Resistance Point 56.92
1st Resistance Point 56.54
Last Price 56.16
1st Support Level 55.78
2nd Support Level 55.40
3rd Support Level 55.02

See More

52-Week High 62.89
Last Price 56.16
Fibonacci 61.8% 55.11
Fibonacci 50% 52.70
Fibonacci 38.2% 50.30
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.